David G. Beer mainly investigates Adenocarcinoma, Cancer research, Lung cancer, Pathology and Cancer. His research in Adenocarcinoma intersects with topics in Immunohistochemistry, Gene expression, Gene expression profiling, Molecular biology and Esophagus. The study incorporates disciplines such as Oncogene, Esophageal disease, CDKN2A, Gene duplication and Barrett's esophagus in addition to Cancer research.
His Lung cancer research is multidisciplinary, incorporating elements of Metastasis, Carcinoma and Lung. David G. Beer works mostly in the field of Pathology, limiting it down to concerns involving Respiratory disease and, occasionally, Candidate gene and Lymphocyte. His Cancer research includes themes of Notch signaling pathway, Immunology and Ectopic expression.
David G. Beer mostly deals with Cancer research, Adenocarcinoma, Lung cancer, Internal medicine and Cancer. As a member of one scientific family, he mostly works in the field of Cancer research, focusing on Cell culture and, on occasion, Apoptosis. His work carried out in the field of Adenocarcinoma brings together such families of science as Immunohistochemistry, Pathology, Molecular biology, Lung and Esophagus.
His Molecular biology research incorporates themes from Gene duplication, Cell, Messenger RNA and Small interfering RNA. His Lung cancer research is multidisciplinary, relying on both Gene expression, Gene expression profiling, Bioinformatics, Stage and Tumor progression. His study on Internal medicine also encompasses disciplines like
His primary scientific interests are in Cancer research, Lung cancer, Internal medicine, Oncology and Cancer. His Cancer research research integrates issues from Cell growth, Apoptosis, Cell cycle, Immune system and microRNA. He interconnects Clinical trial, Metastasis, Lung and Adenocarcinoma in the investigation of issues within Lung cancer.
His work on Colon adenocarcinoma as part of general Adenocarcinoma research is often related to Characterization, thus linking different fields of science. He combines subjects such as Stage, Surgery, Gene, Hazard ratio and Cohort with his study of Oncology. His studies deal with areas such as MEG3, Dysplasia and Gene regulatory network as well as Cancer.
The scientist’s investigation covers issues in Lung cancer, Cancer research, Cancer, Adenocarcinoma and Oncology. The Lung cancer study combines topics in areas such as Stage, Metastasis and Lung. His Metastasis research incorporates elements of Stage classification and Pathology.
His Cancer research study combines topics from a wide range of disciplines, such as Cell growth, Immune system, Immunotherapy, Chromatin and microRNA. His Cancer research focuses on subjects like Long non-coding RNA, which are linked to Cell, Cell biology, MRNA stabilization, Zebrafish and Ectopic expression. Adenocarcinoma is closely attributed to Survival rate in his work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet.
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.
William D. Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G. Nicholson.
Proceedings of the American Thoracic Society (2011)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer
William D. Travis;Hisao Asamura;Alexander A. Bankier;Mary Beth Beasley.
Journal of Thoracic Oncology (2016)
Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung
Mitch Raponi;Yi Zhang;Jack Yu;Guoan Chen.
Cancer Research (2006)
Proteomic Analysis of Lung Adenocarcinoma: Identification of a Highly Expressed Set of Proteins in Tumors
Guoan Chen;Tarek G. Gharib;Chiang Ching Huang;Dafydd G. Thomas.
Clinical Cancer Research (2002)
Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma
Kazuyuki Kawakami;Jan Brabender;Reginald V. Lord;Susan Groshen.
Journal of the National Cancer Institute (2000)
An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
Franck M. Brichory;David E. Misek;Anne Marie Yim;Melissa C. Krause.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))
Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: